Author

Jóse García Sánchez

Observed names: José Garcia Sánchez, José García Sanchez

Institution: Hospital Arnau de Vilanova

Observed institutions: Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana, Hospital Arnau de Vilanova

OpenAlex ID: A5111295548

Durvalumab After Sequential Chemoradiotherapy in Stage III, Unresectable NSCLC: The Phase 2 PACIFIC-6 Trial

2022 · Marina C. Garassino, Julien Mazieres, et al. · Journal of Thoracic Oncology · 140

Impact of a comprehensive geriatric assessment to manage elderly patients with locally advanced non-small-cell lung cancers: a multicenter prospective study

2024 · Maria Arnal Rondan, Alfredo Sánchez-Hernández, et al. · Clinical & Translational Oncology · 1

Prognostic value of PD-L1 in patients with metastatic renal cell carcinoma (mRCC) treated with antiangiogenic first line drugs (PROANG-SOGUG study)

2026 · Ignacio Peláez Fernández, Verónica Blanco Lorenzo, et al. · Clinical & Translational Oncology

Correction: Impact of a comprehensive geriatric assessment to manage elderly patients with locally advanced non-small-cell lung cancers: a multicenter prospective study

2024 · Maria Arnal Rondan, Alfredo Sánchez-Hernández, et al. · Clinical & Translational Oncology

Works count: 4

Citation count: 141

H-index: 1

I10-index: 1